Bucumolol

Bucumolol
Names
	IUPAC name 8--5-methylchromen-2-one
Identifiers
CAS Number	58409-59-9;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL349807;
ChemSpider	148482;
KEGG	D01492;
MeSH	C024221
PubChem CID	169787;
UNII	U8WVJ3501L;
	InChI InChI=1S/C17H23NO4/c1-11-5-7-14(16-13(11)6-8-15(20)22-16)21-10-12(19)9-18-17(2,3)4/h5-8,12,18-19H,9-10H2,1-4H3 Key: CIJVBYRUFLGDHY-UHFFFAOYSA-N; InChI=1/C17H23NO4/c1-11-5-7-14(16-13(11)6-8-15(20)22-16)21-10-12(19)9-18-17(2,3)4/h5-8,12,18-19H,9-10H2,1-4H3 Key: CIJVBYRUFLGDHY-UHFFFAOYAD;
	SMILES CC1=C2C=CC(=O)OC2=C(C=C1)OCC(CNC(C)(C)C)O;
Properties
Chemical formula	C17H23NO4
Molar mass	305.374 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references

Bucumolol is a beta-adrenergic antagonist.^[1]

References

^ Nakayama, K; Oshima, T; Koike, H (1981). "Assessment of beta-blockade and the non-specific effect of bucumolol, a beta-adrenergic blocking agent, on atrioventricular conduction in anesthetized dogs". Archives Internationales de Pharmacodynamie et de Thérapie. 254 (1): 145–56. PMID 6121536.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

Zdroj:https://en.wikipedia.org?pojem=Bucumolol
Text je dostupný za podmienok Creative Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších podmienok. Podrobnejšie informácie nájdete na stránke Podmienky použitia.

[1] Nakayama, K; Oshima, T; Koike, H (1981). "Assessment of beta-blockade and the non-specific effect of bucumolol, a beta-adrenergic blocking agent, on atrioventricular conduction in anesthetized dogs". Archives Internationales de Pharmacodynamie et de Thérapie. 254 (1): 145–56. PMID 6121536.

[1]